via Bar-Ilan University
New study finds aspirin use for cardiovascular disease may reduce likelihood of infection
Aspirin is an established, safe, and low-cost medication in long-standing common use in prevention and treatment of cardiovascular diseases, and in the past a pain relief and fever reducing medication. The use of aspirin was very popular during the 1918 Spanish Influenza pandemic, several decades before in-vitro confirmation of its activity against RNA viruses. Studies showed that aspirin, in addition to its well-known anti-inflammatory effects, could modulate the innate and adaptive immune responses helping the human immune system battle some viral infections.
With this information in mind Israeli researchers hypothesized that pre-infection treatment with low-dose aspirin (75mg) use might have a potential beneficial effect on COVID-19 susceptibility and disease duration. A joint team from Leumit Health Services, Bar-Ilan University, and Barzilai Medical Center conducted an observational epidemiological study, utilizing data from Leumit Health Services, a national health maintenance organization in Israel. Their findings were recently published in The FEBS Journal.
The researchers analyzed data of 10,477 persons who had been tested for COVID-19 during the first COVID-19 wave in Israel from February 1, 2020 to June 30, 2020. Aspirin use to avoid the development of cardiovascular diseases in healthy individuals was associated with a 29% lower likelihood of COVID-19 infection, as compared to aspirin non-users. The proportion of patients treated with aspirin was significantly lower among the COVID-19-positive individuals, as compared to the COVID-19-negative ones. And those subjects who had been treated with aspirin were less associated with the likelihood of COVID-19 infection than those who were not. Moreover, the group observed that the conversion time of SARS-CoV-2 PCR test results from positive to negative among aspirin-using COVID-positive patients was significantly shorter, and the disease duration was two-three days shorter, depending upon the patients’ pre-existing conditions.
“This observation of the possible beneficial effect of low doses of aspirin on COVID-19 infection is preliminary but seems very promising,” says Prof. Eli Magen from the Barzilai Medical Center, who led the study.
Original Article: Aspirin and COVID-19
More from: Bar-Ilan University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Aspirin and Covid-19
- COVID-19 vaccines for kids: What you need to know
Learn about the safety and effectiveness of COVID-19 vaccines for kids, the possible side effects, and the benefits of vaccination.
- AstraZeneca withdraws COVID-19 vaccine, citing declining demand
The move ends a turbulent saga for AstraZeneca, which successfully developed a coronavirus shot but struggled to sell it amid competition and the emergence of rare but serious side effects.
- AstraZeneca pulls its COVID-19 vaccine from the European market
The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled.
- Why are Black women more likely to die of cancer? Cancer society launches long-term study
Previous long-term studies by the Cancer Society solidified the link between smoking and lung cancer, tied obesity to a variety of health problems and showed that regular aspirin use can ... the study ...
- FLiRT COVID-19 Variants Are Spreading: What to Know About KP.2 and KP.1.1 Strains
The FLiRT variants are just the latest in a long line of new variants that have surfaced from SARS-CoV-2. These strains are new to the scene and researchers are still learning more about them. However ...
Go deeper with Google Headlines on:
Aspirin and Covid-19
[google_news title=”” keyword=”aspirin and Covid-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Effect of low doses of aspirin on COVID-19 infection
- A third COVID vaccine dose improves defense for some clinically extremely vulnerable patients
A major clinical trial has found that an additional COVID-19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibodies against COVID-19.
- Long-term impact of COVID-19 on body composition explored
To date, the long-term effects of COVID-19 on body composition have not been reported. The current study is a pioneering exploration of this area in COVID-19, with examined parameters including lean ...
- Blood Clots News
Nov. 8, 2023 — Using birth control pills and other hormone-based contraceptives is known to elevate the risk of blood clots, but a new study suggests that this risk largely goes away within two ...
- The Covid-19 Pandemic
With the acute phase of the Covid-19 pandemic fading even as the coronavirus ... All vaccines have at least occasional side effects. But people who say they were injured by Covid vaccines believe ...
- Alpacas May Hold Key to Preventing Covid-19 Infection
“We hope our findings can contribute to the amelioration of the Covid-19 pandemic by encouraging further examination of this nanobody as a therapeutic candidate against this viral infection,” said ...
Go deeper with Google Headlines on:
Effect of low doses of aspirin on COVID-19 infection
[google_news title=”” keyword=”effect of low doses of aspirin on COVID-19 infection” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
[embedyt] https://www.youtube.com/embed?listType=playlist&list=PL0UjJ07OSXC83oV409r1yRju8-ihA1InJ&layout=gallery[/embedyt]